European urology最新文献

筛选
英文 中文
Bridging Evidence Gaps in Upper Tract Urothelial Carcinoma: Divergent Strategies Between the American Urological Association and European Association of Urology Guidelines 弥合上尿路上皮癌的证据差距:美国泌尿外科协会和欧洲泌尿外科协会指南的不同策略
IF 23.4 1区 医学
European urology Pub Date : 2025-10-11 DOI: 10.1016/j.eururo.2025.09.4170
Philipp Korn, Nirmish Singla
{"title":"Bridging Evidence Gaps in Upper Tract Urothelial Carcinoma: Divergent Strategies Between the American Urological Association and European Association of Urology Guidelines","authors":"Philipp Korn, Nirmish Singla","doi":"10.1016/j.eururo.2025.09.4170","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4170","url":null,"abstract":"<h2>Section snippets</h2><section><section><section><h2>Imaging</h2>The EAU guidelines recommend fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging (weak recommendation) as a first-line staging modality in high-risk cases. By contrast, the AUA takes a more conservative position in only recommending FDG PET when standard computed tomography (CT) or magnetic resonance imaging is not feasible.</section><section><h2>Ureteroscopy</h2>The role of ureteroscopy (URS) differs between the two guidelines. While the AUA guidelines strongly recommend URS with biopsy as a standard diagnostic</section></section></section><section><section><h2>Discussion</h2>The management of UTUC remains challenging owing to the limited high-quality data available. Both the AUA and EAU have provided robust evidence-based guidelines on UTUC, but nuanced differences that may have clinical significance are evident from a side-by-side comparison, as summarized in Table 1.Accurate staging remains a cornerstone of UTUC management, particularly given its role in risk stratification. Conventional CT shows low sensitivity of 25% (95% confidence interval [CI] 20–31%), but</section></section>","PeriodicalId":12223,"journal":{"name":"European urology","volume":"35 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.06.012 回复:Emmeli Palmstedt, Marianne ma<s:1> nsson, Jonas Hugosson, rebecca Arnsrud Godtman。主动监测筛查发现的低危和中危前列腺癌:GÖTEBORG-1试验延长随访长达25年。Urol欧元。在出版社。https://doi.org/10.1016/j.eururo.2025.06.012
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.08.035
Ziheng Wang, Xuenan Li, Xin Zhao, Yi Yang
{"title":"Re: Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.06.012","authors":"Ziheng Wang, Xuenan Li, Xin Zhao, Yi Yang","doi":"10.1016/j.eururo.2025.08.035","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.08.035","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"122 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“PRIME” Time for Boosting the Immune Response to Bacillus Calmette-Guérin 增强对卡介苗芽孢杆菌免疫反应的“黄金时间”
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.09.4166
Joshua J. Meeks
{"title":"“PRIME” Time for Boosting the Immune Response to Bacillus Calmette-Guérin","authors":"Joshua J. Meeks","doi":"10.1016/j.eururo.2025.09.4166","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4166","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"1 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification 前列腺癌的组织病理学人工智能:迈向可接近的风险分层
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.09.4164
Irbaz Bin Riaz, Liang Cheng, Rodolfo Montironi
{"title":"Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk Stratification","authors":"Irbaz Bin Riaz, Liang Cheng, Rodolfo Montironi","doi":"10.1016/j.eururo.2025.09.4164","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4164","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"110 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy ip8 - Fluorescence:一项评估荧光共聚焦显微镜实时评估根治性前列腺切除术手术边缘诊断准确性的前瞻性配对队列研究
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.09.4171
Nikhil Mayor, Alexander Light, Anna Silvanto, Aiman Haider, Emma Cullen, Chase Ng, Ranil Johann Boaz, Archana Gopalakrishnan, Bijan Khoubehi, Giles Hellawell, Ricardo Almeida-Magana, Larissa Mendes, Eoin Dinneen, Greg Shaw, Ben Challacombe, Paul Cathcart, Martin J. Connor, Taimur T. Shah, Hashim U. Ahmed, Francesca Fiorentino, Mathias Winkler
{"title":"IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy","authors":"Nikhil Mayor, Alexander Light, Anna Silvanto, Aiman Haider, Emma Cullen, Chase Ng, Ranil Johann Boaz, Archana Gopalakrishnan, Bijan Khoubehi, Giles Hellawell, Ricardo Almeida-Magana, Larissa Mendes, Eoin Dinneen, Greg Shaw, Ben Challacombe, Paul Cathcart, Martin J. Connor, Taimur T. Shah, Hashim U. Ahmed, Francesca Fiorentino, Mathias Winkler","doi":"10.1016/j.eururo.2025.09.4171","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4171","url":null,"abstract":"<h3>Background and objective</h3>Positive surgical margins (PSMs) following radical prostatectomy (RP) are linked to adverse oncological outcomes. Intraoperative margin assessment facilitates immediate secondary resection, enabling more men to undergo “nerve-sparing” RP and improving functional outcomes. Existing techniques, however, have not been adopted widely due to inherent limitations. Fluorescence confocal microscopy (FCM) is a more feasible alternative, offering rapid, high-resolution imaging of unprocessed tissue. This study evaluates the diagnostic performance of FCM for detecting PSMs during RP.<h3>Methods</h3>In this multicentre, prospective, blinded, paired cohort study, men undergoing RP for localised or locally advanced prostate cancer were enrolled across three UK uro-oncology centres between August 17, 2023, and September 23, 2024. FCM was performed on fresh prostatectomy specimens using the Histolog scanner. The whole specimen was examined en face with no tissue resection. Final histopathology served as the reference standard. The primary outcome was the diagnostic performance of FCM for PSM detection on a per-patient level, assessed by sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Multiple definitions of PSMs were evaluated. This study was prospectively registered on ISRCTN (21536411).<h3>Key findings and limitations</h3>A total of 156 patients were recruited. The prevalence of all PSMs was 30.8% (48/156). For all lengths of PSMs, including focally positive and &lt;1 mm margins, sensitivity, specificity, PPV, and NPV were 48% (95% confidence interval 33–63%), 94% (88–98%), 79% (60–92%), and 80% (72–87%), respectively. For PSMs of ≥3 mm, FCM demonstrated sensitivity of 79% (54–94%), specificity of 94% (89–97%), PPV of 71% (48–89%), and NPV of 96% (91–99%). Of the false negative cases, 84% were ≤2 mm; 52% were at the apex.<h3>Conclusions and clinical implications</h3>FCM is a feasible, rapid technique for intraoperative margin assessment in RP. Its diagnostic accuracy is reasonable for clinically significant, longer PSMs, but limited for shorter margins, particularly at the apex. These findings support further evaluation in a clinical utility study to determine whether intraoperative FCM can guide surgical decision-making, optimise nerve sparing, and ultimately improve oncological and functional outcomes.","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019 回复:Nicolas Demogeot, Paul Sargos, Julia saleron等。短期雄激素剥夺疗法和高剂量放疗治疗中高风险局限性前列腺癌:来自GETUG 14随机3期试验的结果Urol欧元。在出版社。https://doi.org/10.1016/j.eururo.2025.07.019
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.09.4167
Federico Iori, Emanuele Alì, Cinzia Iotti
{"title":"Re: Nicolas Demogeot, Paul Sargos, Julia Salleron, et al. Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.019","authors":"Federico Iori, Emanuele Alì, Cinzia Iotti","doi":"10.1016/j.eururo.2025.09.4167","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4167","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"74 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Polygenic Risk Scores for Depression, Anxiety, and Neuroticism with Lower Urinary Tract Symptoms Among Women 女性抑郁、焦虑和神经质多基因风险评分与下尿路症状的关联
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.09.4154
Zayn Rajan, Christina Dardani, Kimberley Burrows, Oliver Bastiani, Marcus J. Drake, Carol Joinson
{"title":"Association of Polygenic Risk Scores for Depression, Anxiety, and Neuroticism with Lower Urinary Tract Symptoms Among Women","authors":"Zayn Rajan, Christina Dardani, Kimberley Burrows, Oliver Bastiani, Marcus J. Drake, Carol Joinson","doi":"10.1016/j.eururo.2025.09.4154","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4154","url":null,"abstract":"<h3>Background and objective</h3>Observational studies have found that depression, anxiety, and neuroticism are prospectively associated with lower urinary tract symptoms (LUTS) among women, but are limited by confounding and measurement errors. We examined whether genetic liability for these psychiatric traits is associated with LUTS among women.<h3>Methods</h3>Participants were from the mothers cohort of the Avon Longitudinal Study of Parents and Children (ALSPAC). Polygenic risk scores (PRSs) for depression, anxiety, and neuroticism were calculated using summary data from genome-wide association studies. LUTS were assessed using validated questionnaires at two time points: 2002–2004 (<em>n</em> = 4758; median age 40 yr, interquartile range [IQR] 37–43) and 2011–2012 (<em>n</em> = 3026; median age 50 yr, IQR 47–53). Separate logistic regression models, adjusted for age and population structure, were fitted to examine the association of each PRS with each LUTS.<h3>Key findings and limitations</h3>The neuroticism PRS was associated with nocturia at both time points [odds ratio and 95% confidence intervals=1.24 (1.10,1.40) and 1.21 (1.07,1.37)], and with any urinary incontinence (UI), any urgency, and mixed UI (2002-04) [1.14 (1.05,1.23), 1.12 (1.02,1.23), and 1.23 (1.07,1.43), respectively]. The depression PRS was associated with nocturia [OR 1.33, 95% CI 1.17–1.50) and 1.24 (1.09,1.40)] and any UI [1.09 (1.01,1.18); 1.11 (1.02,1.20)] at both time points, and with any urgency (2011-12) [1.13 (1.03,1.24)]. The anxiety PRS was associated with mixed UI (2002-04) [1.20 (1.03,1.39)]. Limitations include PRS not capturing all genetic liability, potential pleiotropic effects, and restriction of the cohort to parous women of predominantly European ancestry.<h3>Conclusions and clinical implications</h3>Genetic liability for depression, anxiety, and neuroticism is associated with higher risk of LUTS among women. This finding indicates a potential shared aetiology or a possible contribution of mental health problems in the development of LUTS.","PeriodicalId":12223,"journal":{"name":"European urology","volume":"35 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Comprehensive Tumor-immune Profiling Reveals Mediators of Paradoxical Immune Sensitivity in Sarcomatoid Renal Cell Carcinoma 综合肿瘤免疫分析揭示了类肉瘤肾细胞癌中矛盾免疫敏感性的介质
IF 23.4 1区 医学
European urology Pub Date : 2025-10-10 DOI: 10.1016/j.eururo.2025.09.4160
Hangbiao Zhang, Yifan Liu, Bingnan Lu, Yuntao Yao, Xingang Cui, Xiuwu Pan
{"title":"Re: Comprehensive Tumor-immune Profiling Reveals Mediators of Paradoxical Immune Sensitivity in Sarcomatoid Renal Cell Carcinoma","authors":"Hangbiao Zhang, Yifan Liu, Bingnan Lu, Yuntao Yao, Xingang Cui, Xiuwu Pan","doi":"10.1016/j.eururo.2025.09.4160","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.09.4160","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"35 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145261005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Laura Manuela Olarte Bermúdez, Ana M. Rendón-Garavito, and Juan Francisco Ayala’s Letter to the Editor re: Andreas Skolarikos, Robert Geraghty, Bhaskar Somani, et al. European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. Eur Urol 2025;88:64–75 回复Laura Manuela Olarte Bermúdez, Ana M. Rendón-Garavito和Juan Francisco Ayala给编辑的信re: Andreas Skolarikos, Robert Geraghty, Bhaskar Somani等。欧洲泌尿外科协会尿石症的诊断和治疗指南。欧元2025;88:64 - 75
IF 23.4 1区 医学
European urology Pub Date : 2025-10-09 DOI: 10.1016/j.eururo.2025.08.023
Andreas Skolarikos, Robert Geraghty, Bhaskar Somani, Lazaros Tzelves
{"title":"Reply to Laura Manuela Olarte Bermúdez, Ana M. Rendón-Garavito, and Juan Francisco Ayala’s Letter to the Editor re: Andreas Skolarikos, Robert Geraghty, Bhaskar Somani, et al. European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis. Eur Urol 2025;88:64–75","authors":"Andreas Skolarikos, Robert Geraghty, Bhaskar Somani, Lazaros Tzelves","doi":"10.1016/j.eururo.2025.08.023","DOIUrl":"https://doi.org/10.1016/j.eururo.2025.08.023","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"85 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145247480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Platinum Hall of Fame 白金名人堂
IF 25.2 1区 医学
European urology Pub Date : 2025-10-09 DOI: 10.1016/j.eururo.2025.09.4135
{"title":"Platinum Hall of Fame","authors":"","doi":"10.1016/j.eururo.2025.09.4135","DOIUrl":"10.1016/j.eururo.2025.09.4135","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"88 5","pages":"Pages e87-e98"},"PeriodicalIF":25.2,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145247872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信